Clascoterone

(Winlevi®)

Winlevi®

Drug updated on 11/15/2023

Dosage FormCream (topical: 1%)
Drug ClassAndrogen receptor inhibitors
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • For the topical treatment of acne vulgaris in patients 12 years of age and older.

Product Monograph / Prescribing Information

Document TitleYearSource
Winlevi (clascoterone) Prescribing Information.2021Sun Pharmaceutical Industries, Inc. Cranbury, NJ

Systematic Reviews / Meta-Analyses